Pharma Journalist -

Syndax Pharmaceuticals and Nektar Therapeutics announced a non-exclusive, clinical collaboration to evaluate the safety and efficacy of Nektar's NKTR-214, a CD122-biased agonist, in…
Read More...

SMi's 2nd annual Ophthalmic Drugs Conference returning to London, taking place at the Copthorne Tara Hotel in Kensington, on the 26th - 27th November 2018. As the global population…
Read More...

How would you feel if you were scheduled in for a operation only to hear that your surgeon was being replaced by a robot? Whilst this isn’t quite the stage machine intelligence in…
Read More...

Being the most talked about department within R&D,Cell & Gene Therapy will explore the latest advancements of advanced therapy medicinal products (ATMPs) by discussing, the…
Read More...

Shuwen Biotech announced that it has signed a partnership agreement with Bliss Biopharmaceutical Co., Ltd., a biopharmaceutical company engaged in the discovery, development and…
Read More...

Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) submitted by its collaboration partner Loxo Oncology, Inc. (NASDAQ: LOXO),…
Read More...

Evotec AG announced that the Company will receive a $ 6 m payment from Celgene following Celgene's decision to expand the collaboration to include additional cell lines. Evotec and…
Read More...

Astellas Pharma announced today that the U.S. Food and Drug Administration (FDA) has accepted, with Priority Review, the company's New Drug Application (NDA) for gilteritinib for the…
Read More...

Luye Pharma Group recently announced their acquisition of AstraZeneca's core CNS products - Seroquel and Seroquel XR. As with previous acquisitions such as Lipusu, Xuezhikang, Beixi and…
Read More...

Braeburn announces the resubmission of the New Drug Application (NDA) for CAM2038, an investigational buprenorphine flexible-dose weekly and monthly depot injection for the treatment of…
Read More...